Summary
G protein-coupled receptors (GPCRs) make up the largest and most diverse family of membrane receptors in the human genome, relaying information about the presence of diverse extracellular stimuli to the cell interior. All known GPCRs share a common architecture of seven membrane-spanning helices connected by intra- and extracellular loops. Most GPCR-mediated cellular responses result from the receptor acting as a ligand-activated guanine nucleotide exchange factor for heterotrimeric guanine nucleotide-binding (G) proteins whose dissociated subunits activate effector enzymes or ion chan-nels. GPCR signaling is subject to extensive negative regulation through receptor desensitization, sequestration, and down regulation, termination of G protein activation by GTPase-activation proteins, and enzymatic degradation of second messengers. Addi-tional protein—protein interactions positively modulate GPCR signaling by influencing ligand-binding affinity and specificity, coupling between receptors, G proteins and effectors, or targeting to specific subcellular locations. These include the formation of GPCR homo- and heterodimers, the interaction of GPCRs with receptor activity-modi-fying proteins, and the binding of various scaffolding proteins to intracellular receptor domains. In some cases, these processes appear to generate signals in conjunction with, or even independent of, G protein activation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lander E. S., Linton L. M., Birren B., Nusbaum C., Zody M. C., Baldwin J., et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860–921.
Venter J. C., Adams M. D., Myers E. W., Li P. W., Mural R. J., Sutton G. G., et al. (2001) The sequence of the human genome. Science 291, 1304–1351.
Bargmann C. (1998) Neurobiology of the Caenorhabditis elegans genome. Science 282, 2028–2033.
Flower D. R. (1999) Modelling G-protein-coupled receptors for drug design. Biochim. Biophys. Acta. 1422, 207–234.
Fredriksson R., Lagerstrom M. C., Lundin L. G., and Schioth H. B. (2003) TheG-protein-coupled receptors in the human genome form five main families. Phylogeneticanalysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256–1272.
Birnbaumer L., Pohl S. L., Michiel H., Krans M. J., and Rodbell M. (1970) The actions of hormones on the adenyl cyclase system. Adv. Biochem. Psychopharmacol. 3, 185–208.
Insel P. A., Maguire M. E., Gilman A. G., Bourne H. R., Coffino P., and Melmon K. L. (1976) Beta adrenergic receptors and adenylate cyclase: productsof separate genes? Mol. Pharmacol. 12, 1062–1069.
Gilman A. G. (1987) G proteins: transducers of receptor-generated signals. Ann. Rev. Biochem. 56, 615–649.
Sternweis P. C. and Gilman A. G. (1979) Reconstitution of catecholamine-sensi-tiveadenylate cyclase. Reconstitution of the uncoupled variant of the S49 lym-phomacell. J. Biol. Chem. 254, 3333–3340.
Northup J. K., Sternweis P. C., Smigel M. D., Schleifer L. S., Ross E. M., and Gilman A. G. (1980) Purification of the regulatory component of adenylate cy-clase. Proc. Natl. Acad. Sci. USA 77, 6516–6520.
Manning D. R. and Gilman A. G. (1983) The regulatory components of adeny-latecyclase and transducin. A family of structurally homologous guanine nucle-otide-binding proteins. J. Biol. Chem. 258, 7059–7063.
Lefkowitz R. J. (2000) The superfamily of heptahelical receptors. Nat. Cell Biol. 2, E133–E136.
Palczewski K., Kumasaka T., Hori T., Behnke C. A., Motoshima H., Fox B. A., et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739–745.
Kolakowski L. F., Jr. (1994) GCRDb: A G-protein coupled receptor database. Recept. Channels 2, 1–7.
Perez D. M. (2003) The evolutionarily triumphant G protein-coupled receptor. Mol. Pharmacol. 63, 1202–1205.
Arshavsky V. Y., Lamb T. D., and Pugh E. N., Jr. (2002) G proteins andphototransduction. Ann. Rev. Physiol. 64, 153–187.
Ridge K. D., Abdulaev N. G., Sousa M., and Palczewski K. (2003) Phototransduction: Crystal clear. Trends Biochem. Sci. 28, 479–487.
Gether U. and Kobilka B. K. (1998) G protein-coupled receptors. II. Mechanismof agonist activation. J. Biol. Chem. 273, 17,979–17,982.
De Lean A., Stadel J. M., and Lefkowitz R. J. (1980) A ternary complex modelexplains the agonist-specific binding properties of the adenylate cyclase-coupledbeta-adrenergic receptor. J. Biol. Chem. 255, 7108–7117.
Samama P., Cotecchia S., Costa T., and Lefkowitz R. J. (1993) A mutation-inducedactivated state of the beta 2-adrenergic receptor. Extending the ternarycomplex model. J. Biol. Chem. 268, 4625–4536.
Lefkowitz R. J., Cotecchia S., Samama P., and Costa T. (1993) Constitutiveactivity of receptors coupled to guanine nucleotide regulatory proteins. TrendsPharmacol. Sci. 14, 303–307.
Kenakin T. (2002) Drug efficacy at G protein-coupled receptors. Ann. Rev. Pharmacol. Toxicol. 42, 349–379.
Kenakin T. (2003) Ligand-selective receptor conformations revisited: the prom-iseand the problem. Trends Pharmacol. Sci. 24, 346–354.
Gurevich V. V., Pals-Rylaarsdam R., Benovic J. L., Hosey M. M., and Onorato J. J. (1997) Agonist-receptor-arrestin, an alternative ternary complex with highagonist affinity. J. Biol. Chem. 272, 28,849–28,852.
Key T. A., Bennett T. A., Foutz T. D., Gurevich V. V., Sklar L. A., and Prossnitz E. R. (2001) Regulation of formyl peptide receptor agonist affinity byreconstitution with arrestins and heterotrimeric G proteins. J. Biol. Chem. 276, 49,204–49,212.
Swaminath G., Xiang Y., Lee T. W., Steenhuis J., Parnot C., and Kobilka B. K. (2004) Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evi-dencefor intermediate conformational states. J. Biol. Chem. 279, 686–691.
Whistler J. L. and von Zastrow M. (1998) Morphine-activated opioid receptorselude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. USA 95, 9914–9919.
Kohout T. A., Nicholas S. L., Perry S. J., Reinhart G., Junger S., and Struthers R. S. (2004) Differential desensitization, receptor phosphorylation, beta-arrestinrecruitment, and ERK1/2 activation by the two endogenous ligands for the CCchemokine receptor 7. J. Biol. Chem. 279, 23,214–23,222.
Holloway A. C., Qian H., Pipolo L., Ziogas J., Miura S., Karnik S., et al. (2002) Side-chain substitutions within angiotensin II reveal different requirementsfor signaling, internalization, and phosphorylation of type 1a angiotensin recep-tors. Mol. Pharmacol. 61, 768–777.
Wei H., Ahn S., Shenoy S. K., Karnik S. S., Hunyady L., Luttrell L. M., and Lefkowitz R. J. (2003) Independent beta-arrestin 2 and G protein-mediated path-waysfor angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. USA 100, 10,782–10,787.
Downes G. B. and Gautam N. (1999) The G protein subunit gene families. Genomics 62, 544–552.
Schmidt C. J., Thomas T. C., Levine M. A., and Neer N. J. (1992) Specificity of G protein beta and gamma subunit interactions. J. Biol. Chem. 267, 13,807–13,810.
Hildebrandt J. D. (1997) Role of subunit diversity in signaling by heterotrimericG proteins. Biochem. Pharmacol. 54, 325–339.
Ford C. E., Skiba N. P., Bae H., Daaka Y., Reuveny E., Shekter L. R., et al. (1998) Molecular basis for interactions of G protein betagamma subunits witheffectors. Science 280, 1271–1274.
Sprang S. R. (1997) G protein mechanisms: Insights from structural analysis. Ann. Rev. Pharmacol, Toxicol. 36, 461–480.
Coleman D. E. and Sprang S. R. (1996) How G proteins work: A continuingstory. Trends. Biochem. Sci. 21, 41–44.
Casey P. J. (1994) Lipid modifications of G proteins. Curr. Opin. Cell Biol. 6, 219–225.
Clapham D. E. and Neer E. J. (1993) New roles for G-protein beta gamma-dimersin transmembrane signalling. Nature 365, 403–406.
Zwartkruis F. J. and Bos J. L. (1999) Ras and Rap1: Two highly related smallGTPases with distinct function. Exp. Cell Res. 253, 157–165.
Sunahara R. K., Dessauer C. W., and Gilman A. G. (1996) Complexity anddiversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol. 36, 461–480.
Morris A. J. and Scarlata S. (1997) Regulation of effectors by G-protein alpha-andbeta gamma-subunits. Recent insights from studies of the phospholipase c-betaisoenzymes. Biochem. Pharmacol. 54, 429–435.
Wickman K. D. and Clapham D. E. (1995) G-protein regulation of ion channels. Curr. Opin. Neurobiol. 5, 278–285.
Albert P. R. and Robillard L. (2002) G protein specificity: Traffic direction re-quired. Cell. Signal. 14, 407–418.
Stoffel R. H. 3rd, Pitcher J. A., and Lefkowitz R. J. (1997) Targeting G protein-coupledreceptor kinases to their receptor substrates. J. Membr. Biol. 157, 1–8.
Perry S. J., Baillie G. S., Kohout T. A., McPhee I., Magiera M. M., Ang K. L., et al. (2002) Targeting of cyclic AMP degradation to beta 2-adrenergic receptorsby beta-arrestins. Science 298, 834–836.
Baillie G. S., Sood A., McPhee I., et al. (2003) Beta-Arrestin-mediated PDE4cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching fromGs to Gi. Proc. Natl. Acad. Sci. USA 100, 940–945.
Ross E. M. (1995) G protein GTPase-activating proteins: Regulation of speed, amplitude, and signaling selectivity. Recent Prog. Horm. Res. 50, 207–221.
Ross E. M. and Wilkie T. M. (2000) GTPase-activating proteins forheterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-likeproteins. Annu. Rev. Biochem. 69, 795–827.
Berman D. M. and Gilman A. G. (1998) Mammalian RGS proteins: Barbariansat the gate. J. Biol. Chem. 273, 1269–1272.
Schulz R. (2001) The pharmacology of phosducin. Pharmacol. Res. 43, 1–10.
Pitcher J., Lohse M. J., Codina J., Caron M. G., and Lefkowitz R. J. (1992) Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic re-ceptorkinase, cAMP-dependent protein kinase, and protein kinase C occurs viadistinct molecular mechanisms. Biochemistry 31, 3193–3197.
Freedman N. J. and Lefkowitz R. J. (1996) Desensitization of G protein-coupledreceptors. Recent Prog. Horm. Res. 51, 319–351.
Daaka Y., Luttrell L. M., and Lefkowitz R. J. (1997) Switching of the couplingof the beta2-adrenergic receptor to different G proteins by protein kinase A. Na-ture 390, 88–91.
Zamah A. M., Delahunty M., Luttrell L. M., and Lefkowitz R. J. (2002) Proteinkinase A-mediated phosphorylation of the beta2-adrenergic receptor regulates itscoupling to Gs and Gi. Demonstration in a reconstituted system. J. Biol. Chem. 277, 31,249–31,256.
Lawler O. A., Miggin S. M., and Kinsella B. T. (2001) Protein kinase A-medi-atedphosphorylation of serine 357 of the mouse prostacyclin receptor regulatesits coupling to Gs-, to Gi-and to Gq-coupled effector signaling. J. Biol. Chem. 276, 33,596–33,607.
Lefkowitz R. J., Pierce K. L., and Luttrell L. M. (2002) Dancing with differentpartners: Protein kinase A phosphorylation of seven membrane-spanning recep-torsregulates their G protein-coupling specificity. Mol. Pharmacol. 62, 971–974.
Lohse M. J., Andexinger S., Pitcher J., et al. (1993) Receptor specific desensiti-zationwith purified proteins. Kinase dependence and receptor specificity of β-arrestin and arrestin in the β2-adrenergic receptor and rhodopsin systems. J. Biol. Chem. 267, 8558–8564.
Ferguson S. S. (2001) Evolving concepts in G protein-coupled receptor endocy-tosis:the role in receptor desensitization and signaling. Pharm. Rev. 53, 1–24.
Luttrell L. M., and Lefkowitz R. J. (2002) The role of beta-arrestins in the termi-nationand transduction of G-protein-coupled receptor signals. J. Cell. Sci. 115, 455–465.
Goodman O. B., Jr., Krupnick J. G., Santini F., et al. (1996) Beta-arrestin acts asa clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383, 447–450.
Laporte S. A., Oakley R. H., Zhang J., et al. (1999) The beta2-adrenergic recep-tor/beta-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. USA 96, 3712–3717.
Carman C. V., Parent J. L., Day P. W., et al. (1999) Selective regulation ofGalpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J. Biol. Chem. 274, 34,483–34,492.
Lodowski D. T., Pitcher J. A., Capel W. D., Lefkowitz R. J., and Tesmer J. J. (2003) Keeping G proteins at bay: a complex between G protein-coupled receptorkinase 2 and G beta gamma. Science 300, 1256–1262.
Dhami G. K., Dale L. B., Anborgh P. H., O’Connor-Halligan K. E., Sterne-Marr R., and Ferguson S. S. (2004) G Protein-coupled receptor kinase 2 RGShomology domain binds to both metabotropic glutamate receptor 1a and G alphaq to attenuate signaling. J. Biol. Chem. 279, 16,614–16,620.
Barak L. S., Ferguson S. S., Zhang J., and Caron M. G. (1997) A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor acti-vation. J. Biol. Chem. 272, 27,497–27,500.
Oakley R. H., Laporte S. A., Holt J. A., Barak L. S., and Caron M. G. (2001) Molecular determinants underlying the formation of stable intracellular G pro-tein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J. Biol. Chem. 276, 19,452–19,460.
Oakley R. H., Laporte S. A., Holt J. A., Caron M. G., and Barak L. S. (2000) Differential affinities of visual arrestin, beta-arrestin1, and beta-arrestin2 for Gprotein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275, 17,201–17,210.
Kohout T. A., Lin F-T., Perry S. J., Conner D. A., and Lefkowitz R. J. (2001) Beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling andtrafficking. Proc. Natl. Acad. Sci. USA 98, 1601–1606.
Lin F-T., Krueger K. M., Kendall H. E., et al. (1997) Clathrin-mediated endocy-tosisof the beta-adrenergic receptor is regulated by phosphorylation/dephospho-rylationof beta-arrestin1. J. Biol. Chem. 272, 31,051–31,057.
Lin F-T., Chen W., Shenoy S., Cong M., Exum S. T., and Lefkowitz R. J. (2002) Phosphorylation of beta-arrestin2 regulates it function in internalization ofbeta(2)-adrenergic receptors. Biochemistry 41, 10,692–10,699.
Shenoy S. K., McDonald P. H., Kohout T. A., and Lefkowitz R. J. (2001) Regu-lationof receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin. Science 294, 1307–1313.
Martin N. P., Lefkowitz R. J., and Shenoy S. K. (2003) Regulation of V2 vasopressinreceptor degradation by agonist-promoted ubiquitination. J. Biol. Chem. 278, 45,954–45,959.
Shenoy S. K. and Lefkowitz R. J. (2003) Trafficking pattern of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestindeubiquitination. J. Biol. Chem. 278, 14,498–14,506.
Paing M. M., Stutts A. B., Kohout T. A., Lefkowitz R. J., and Trejo J. (2002) Beta-arrestins regulate protease-activated receptor-1 desensitization but not inter-nalizationor down-regulation. J. Biol. Chem. 277, 1292–1300.
Vines C. M., Revankar C. M., Maestas D. C., et al. (2003) N-formyl peptidereceptors internalize but do not recycle in the absence of arrestins. J. Biol. Chem. 278, 41,581–41,584.
Brasselet S., Guillen S., Vincent J. P., and Mazella J. (2002) Beta-arrestin isinvolved in the desensitization but not in the internalization of the somatostatinreceptor 2A expressed in CHO cells. FEBS Lett. 10, 124–128.
Zhang J., Ferguson S. S., Barak L. S., Menard L., and Caron M. G. (1996) Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled re-ceptorinternalization. J. Biol. Chem. 271, 18,302–18,305.
Vogler O., Nolte B., Voss M., Schmidt M., Jakobs K. H., and van Koppen C. J. (1999) Regulation of muscarinic acetylcholine receptor sequestration and func-tionby beta-arrestin. J. Biol. Chem. 274, 12,333–12,338.
Rapacciuolo A., Suvarna S., Barki-Harrington L., et al. (2003) Phosphorylationsites of the beta-1 adrenergic receptor determine the internalization pathway. J. Biol. Chem. 278, 35,403–35,411.
Pitcher J. A., Payne E. S., Csortos C., DePaoli-Roach A. A., and Lefkowitz R. J. (1995) The G-protein-coupled receptor phosphatase: a protein phosphatase type2A with a distinct subcellular distribution and substrate specificity. Proc. Natl. Acad. Sci. USA 92, 8343–8347.
Oakley R. H., Laporte S. A., Holt J. A., Barak L. S., and Caron M. G. (1999) Association of beta-arrestin with G protein-coupled receptors during clathrin-mediatedendocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274, 32,248–32,257.
Dale L. B., Seachrist J. L., Babwah A. V., and Ferguson S. S. (2004) Regula-tionof angiotensin II type 1A receptor intracellular retention, degradation, andrecycling by Rab5, Rab7, and Rab11 GTPases. J. Biol. Chem. 279, 13,110–13,118.
Seachrist J. L. and Ferguson S. S. (2003) Regulation of G protein-coupled recep-torendocytosis and trafficking by Rab GTPases. Life Sci. 74, 225–235.
Cao T. T., Deacon H. W., Reczek D., Bretscher A., and von Zastrow M. (1999) A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 401, 286–290.
Whistler J. L., Enquist J., Marley A., et al. (2002) Modulation of postendocyticsorting of G protein-coupled receptors. Science 297, 529–531.
Gage R. M., Kim K. A., Cao T. T., and von Zastrow M. (2001) A transplantablesorting signal that is sufficient to mediate rapid recycling of G protein-coupledreceptors. J. Biol. Chem. 276, 44,712–44,720.
Premont R. T., Claing A., Vitale N., et al. (1998) Beta2-Adrenergic receptorregulation by GIT1, a G protein-coupled receptor kinase-associated ADPribosylation factor GTPase-activating protein. Proc. Natl. Acad. Sci. USA 95, 14,082–14,087.
Claing A., Chen W., Miller W. E., et al. (2001) Beta-Arrestin-mediated ADP-ribosylationfactor 6 activation and beta 2-adrenergic receptor endocytosis. J. Biol. Chem. 276, 42,509–42,513.
Devi L. (2001) Heterodimerization of G-protein-coupled receptors: pharmacol-ogy, signaling and trafficking. Trends Pharmacol. Sci. 22, 532–537.
Milligan G. (2001) Oligomerisation of G-protein-coupled receptors. J. Cell Sci. 114, 1265–1271.
Angers S., Salahpour A., and Bouvier M. (2002) Dimerization: An emergingconcept for G protein-coupled receptor ontogeny and function. Ann. Rev. Pharmacol. Toxicol. 42, 409–435.
Nakanishi-Matsui M., Zheng Y. W., Sulciner D. J., et al. (2000) PAR3 is acofactor for PAR4 activation by thrombin. Nature 404, 609–613.
O’Brien P. J., Prevost N., Molino M., et al. (2000) Thrombin responses in hu-manendothelial cells. Contributions from receptors other than PAR1 include thetransactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275, 13,502–13,509.
Baneres J. L. and Parello J. (2003) Structure-based analysis of GPCR function:Evidence for a novel pentameric assembly between the dimeric leukotriene B4receptor BLT1 and the G-protein. J. Mol. Biol. 329, 815–829.
Marshall G. R. (2001) Peptide interactions with G-protein coupled receptors. Biopolymers 60, 246–277.
Fotiadis D., Liang Y., Filipek S., Saperstein D. A., Engel A., and Palczewski K. (2003) Atomic-force microscopy: Rhodopsin dimers in native disc mem-branes. Nature 421, 127–128.
Jones K. A., Borowsky B., Tamm J. A., et al. (1998) GABA(B) receptors func-tionas a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396, 674–679.
Kaupmann K., Malitschek B., Schuler V., et al. (1998) GABA(B)-receptor sub-typesassemble into functional heteromeric complexes. Nature 396, 683–687.
Kniazeff J., Galvez T., Labesse G., and Pin J. P. (2002) No ligand binding inthe GB2 subunit of the GABA(B) receptor is required for activation and allos-tericinteraction between the subunits. J. Neurosci. 22, 7352–7361.
Robbins M. J., Calver A. R., Filippov A. K., et al. (2001) GABA(B2) is essen-tialfor G-protein coupling of the GABA(B) receptor heterodimer. J. Neurosci. 21, 8043–8052.
Margeta-Mitrovic M., Jan Y. N., and Jan L. Y. (2000) A trafficking checkpointcontrols GABA(B) receptor heterodimerization. Neuron 27, 97–106.
Ng G. Y., O’Dowd B. F., Lee S. P., et al. (1996) Dopamine D2 receptor dimersand receptor-blocking peptides. Biochem. Biophys. Res. Commun. 227, 200–204.
Schulz A., Grosse R., Schultz G., Gudermann T., and Schoneberg T. (2000) Structural implication for receptor oligomerization from functional reconstitu-tionstudies of mutant V2 vasopressin receptors. J. Biol. Chem. 275, 2381–2389.
Vila-Coro A. J., Rodriguez-Frade J. M., Martin de Ana A., Moreno-Ortiz M. C., Martinez A. C., and Mellado M. (1999) The chemokine SDF-1alpha trig-gersCXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13, 1699–1710.
Rodriguez-Frade J. M., Vila-Coro A. J., Martin de Ana A. M., Albar J. P., Martinez A. C., and Mellado M. (1999) The chemokine monocyte chemoattrac-tantprotein-1 induces functional responses through dimerization of its receptorCCR2. Proc. Natl. Acad. Sci. USA 96, 3628–3633.
Vila-Coro A. J., Mellado M., Martin de Ana A., et al. (2000) HIV-1 infectionthrough the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. USA 97, 3388–3393.
Jordan B. A. and Devi L. A. (1999) G-protein-coupled receptorheterodimerization modulates receptor function. Nature 399, 697–700.
George S. R., Fan T., Xie Z., et al. (2000) Oligomerization of mu-and delta-opioidreceptors. Generation of novel functional properties. J. Biol. Chem. 275, 26,128–26,135.
AbdAlla S., Lother H., and Quitterer U. (2000) AT1-receptor heterodimersshow enhanced G-protein activation and altered receptor sequestration. Nature 407, 94–98.
AbdAlla S., Lother H., el Massiery A., and Quitterer U. (2001) Increased AT(1)receptor heterodimers in preeclampsia mediate enhanced angiotensin II respon-siveness. Nat. Med. 7, 1003–1009.
Barki-Harrington L., Luttrell L. M., and Rockman H. A. (2003) Dual inhibitionof beta-adrenergic and angiotensin II receptors by a single antagonist: a func-tionalrole for receptor-receptor interaction in vivo. Circulation 108, 1611–1618.
Kroeger K. M., Pfleger K. D., and Eidne K. A. (2003) G-protein coupled recep-toroligomerization in neuroendocrine pathways. Front. Neuroendocrinol. 24, 254–278.
Breitwieser G. E. (2004) G protein-coupled receptor oligomerization: Implica-tionsfor G protein activation and cell signaling. Circ. Res. 94, 17–27.
Terrillon S. and Bouvier M. (2004) Roles of G-protein-coupled receptor dimer-ization. EMBO Rep. 5, 30–34.
Whistler J. L., Chuang H. H., Chu P., Jan L. Y., and von Zastrow M. (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: impli-cationsfor the biology of opiate tolerance and addiction. Neuron 23, 737–746.
Sexton P. M., Albiston A., Morfis M., and Tilakaratne N. (2001) Receptoractivity modifying proteins. Cell. Signal. 13, 73–83.
Foord S. M. and Marshall F. H. (1999) RAMPs: accessory proteins for seventransmembrane domain receptors. Trends Pharmacol. Sci. 20, 184–187.
Brady A. E. and Limbird L. E. (2002) G protein-coupled receptor interactingproteins: Emerging roles in localization and signal transduction. Cell. Signal. 14, 297–309.
Bockaert J., Marin P., Dumuis A., and Fagni L. (2003) The "e;magic tail"e; of Gprotein-coupled receptors: an anchorage for functional protein networks. FEBSLett. 546, 65–72.
Hall R. A., Premont R. T., Chow C. W., et al. (1998) The beta2-adrenergicreceptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+exchange. Nature 392, 626–630.
Mahon M. J., Donowitz M., Yun C. C., and Segre G. V. (2002) Na(+)/H(+)exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417, 858–861.
Mahon M. J. and Segre G. V. (2004) Stimulation by parathyroid hormone of aNHERF-1 assembled complex consisting of the parathyroid hormone I receptor,PLC-beta and actin increases intracellular calcium in OK cells. J. Biol. Chem. 279, 23,550–23,558.
Hu L. A., Tang Y., Miller W. E., et al. (2000) Beta 1-Adrenergic receptor asso-ciationwith PSD-95. Inhibition of receptor internalization and facilitation of beta1-adrenergic receptor interaction with N-methyl-D-aspartate receptors. J. Biol. Chem. 275, 38,659–38,666.
Xu J., Paquet M., Lau A. G., Wood J. D., Ross C. A., and Hall R. A. (2001) Beta 1-Adrenergic receptor association with the synaptic scaffolding proteinmembrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regu-lationof receptor internalization by MAGI-2 and PSD-95. J. Biol. Chem. 276, 41,310–41,317.
Zitzer H., Honck H. H., Bachner D., Richter D., and Kreienkamp H. J. (1999) Somatostatin receptor interacting protein defines a novel family of multidomainproteins present in human and rodent brain. J. Biol. Chem. 274, 32,997–33,001.
Boudin H., Doan A., Xia J., et al. (2000) Presynaptic clustering of mGluR7arequires the PICK1 PDZ domain binding site. Neuron 28, 485–497.
Perroy J., Prezeau L., De Waard M., Shigemoto R., Bockaert J., and Fagni L. (2000) Selective blockade of P/Q-type calcium channels by the metabotropicglutamate receptor type 7 involves a phospholipase C pathway in neurons. J. Neurosci. 20, 7896–7904.
Becamel C., Figge A., Poliak S., et al. (2001) Interaction of serotonin 5-hy-droxytryptaminetype 2C receptors with PDZ10 of the multi-PDZ domain proteinMUPP1. J. Biol. Chem. 276, 12,974–12,982.
Smith F. D., Oxford G. S., and Milgram S. L. (1999) Association of the D2dopamine receptor third cytoplasmic loop with spinophilin, a protein phos-phatase-1-interacting protein. J. Biol. Chem. 274, 19,894–19,900.
Richman J. G., Brady A. E., Wang Q., Hensel J. L., Colbran R. J., and Limbird L. E. (2001) Agonist-regulated Interaction between alpha2-adrenergic receptorsand spinophilin. J. Biol. Chem. 276, 15,003–15,008.
Fagni L., Worley P. F., and Ango F. (2002) Homer as both a scaffold and trans-ductionmolecule. Sci. STKE. 2002(137), RE8.
Ciruela F., Soloviev M. M., and McIlhinney R. A. (1999) Co-expression ofmetabotropic glutamate receptor type 1alpha with homer-1a/Vesl-1S increasesthe cell surface expression of the receptor. Biochem. J. 341, 795–803.
Bermak J. C., Li M., Bullock C., and Zhou Q. Y. (2001) Regulation of trans-portof the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3, 492–498.
Tai A. W., Chuang J. Z., Bode C., Wolfrum U., and Sung C. H. (1999) Rhodopsin’s carboxy-terminal cytoplasmic tail acts as a membrane receptor forcytoplasmic dynein by binding to the dynein light chain Tctex-1. Cell 97, 877–887.
Sung C. H., Makino C., Baylor D., and Nathans J. (1994) A rhodopsin genemutation responsible for autosomal dominant retinitis pigmentosa results in a pro-teinthat is defective in localization to the photoreceptor outer segment. J. Neurosci. 14, 5818–5833.
Shih M., Lin F., Scott J. D., Wang H. Y., and Malbon C. C. (1999) Dynamiccomplexes of beta2-adrenergic receptors with protein kinases and phosphatasesand the role of gravin. J. Biol. Chem. 274, 1588–1595.
Fraser I. D., Cong M., Kim J., et al. (2000) Assembly of an A kinase-anchoringprotein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylationand signaling. Curr. Biol. 10, 409–412.
Cong M., Perry S. J., Lin F. T., et al. (2001) Regulation of membrane targetingof the G protein-coupled receptor kinase 2 by protein kinase A and its anchoringprotein AKAP79. J. Biol. Chem. 276, 15,192–15,199.
Lopez-Ilasaca M., Liu X., Tamura K., and Dzau V. J. (2003) The angiotensinII type I receptor-associated protein, ATRAP, is a transmembrane protein and amodulator of angiotensin II signaling. Mol. Biol. Cell. 14, 5038–5050.
O’Connor V., El Far O., Bofill-Cardona E., et al. (1999) Calmodulin depen-denceof presynaptic metabotropic glutamate receptor signaling. Science 286, 1180–1184.
Li M., Bermak J. C., Wang Z. W., and Zhou Q. Y. (2000) Modulation of dopa-mineD(2) receptor signaling by actin-binding protein (ABP-280). Mol. Pharmacol. 57, 446–452.
Hasegawa H., Katoh H., Fujita H., Mori K., and Negishi M. (2000) Receptorisoform-specific interaction of prostaglandin EP3 receptor with muskelin. Biochem. Biophys. Res. Commun. 276, 350–354.
Prezeau L., Richman J. G., Edwards S. W., and Limbird L. E. (1999) The zetaisoform of 14-3-3 proteins interacts with the third intracellular loop of differentalpha2-adrenergic receptor subtypes. J. Biol. Chem. 274, 13,462–13,469.
Couve A., Kittler J. T., Uren J. M., et al. (2001) Association of GABA(B) re-ceptorsand members of the 14-3-3 family of signaling proteins. Mol. Cell. Neurosci. 17, 317–328.
Kryiakis J. M., and Avruch J. (1996) Sounding the alarm: Protein kinase cas-cadesactivated by stress and inflammation. J. Biol. Chem. 271, 24,313–24,316.
Pearson G., Robinson F., Beers Gibson T., et al. (2001) Mitogen-activated pro-tein(MAP) kinase pathways: Regulation and physiologic functions. Endocr. Rev. 22, 153–183.
van Biesen T., Hawes B. E., Luttrell D. K., et al. (1995) Receptor-tyrosine-kinase-and Gβγ-mediated MAP kinase activation by a common signalling path-way. Nature 376, 781–784.
Luttrell L. M., Hawes B. E., van Biesen T., Luttrell D. K., Lansing T. J., and Lefkowitz R. J. (1996) Role of c-Src in G protein-coupled receptor-and Gβγsubunit-mediated activation of mitogen activated protein kinases. J. Biol. Chem. 271, 19,443–19,450.
Hackel P. O., Zwick E., Prenzel N., and Ullrich A. (1999) Epidermal growthfactor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11, 184–189.
Shah B. H., and Catt K. J. (2004) GPCR-mediated transactivation of RTKs inthe CNS: Mechanisms and consequences. Trends Neurosci. 27, 48–53.
Prenzel N., Zwick E., Daub H., et al. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884–888.
Schafer B., Gschwind A., and Ullrich A. (2004) Multiple G-protein-coupledreceptor signals converge on the epidermal growth factor receptor to promotemigration and invasion. Oncogene 23, 991–999.
Yart A., Roche S., Wetzker R., et al. (2002) A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in responseto lysophosphatidic acid. J. Biol. Chem. 277, 21,167–21,178.
Luttrell L. M., Della Rocca G. J., van Biesen T., Luttrell D. K., and Lefkowitz R. J. (1997) Gβγsubunits mediate Src-dependent phosphorylation of the epider-malgrowth factor receptor. J. Biol. Chem. 272, 4637–4644.
Pierce K. L., Tohgo A., Ahn S., Field M. E., Luttrell L. M., and Lefkowitz R. J. (2001) Epidermal growth factor receptor dependent ERK activation by Gprotein-coupled receptors: A co-culture system for identifying intermediatesupstream and downstream of HB-EGF shedding. J. Biol. Chem. 276, 23,155–23,165.
Asakura M., Kitakaze M., Takashima S., et al. (2002) Cardiac hypertrophy isinhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinaseinhibitors as a new therapy. Nat. Med. 8, 35–40.
Maudsley S., Pierce K. L., Zamah A. M., et al. (2000) The β2-adrenergic recep-tormediates MAP kinase activation via assembly of a multireceptor complexincluding the EGF receptor. J. Biol. Chem. 275, 9572–9580.
Gschwind A., Zwick E., Prenzel N., Leserer M., and Ullrich A. (2001) Cellcommunication networks: epidermal growth factor receptor transactivation asthe paradigm for interreceptor signal transmission. Oncogene 20, 1594–1600.
Murasawa S., Mori Y., Nozawa Y., et al. (1998) Angiotensin II type 1 receptor-inducedextracellular signal-regulated protein kinase activation is mediated byCa2+/calmodulin-dependent transactivation of epidermal growth factor recep-tor. Circ. Res. 82, 1338–1348.
Castagliuolo I., Valenick L., Liu J., and Pothoulakis C. (2000) Epidermalgrowth factor receptor transactivation mediates substance P-induced mitogenicresponses in U-373 MG cells. J. Biol. Chem. 275, 26,545–26,550.
Lev S., Moreno H., Martinez R., et al. (1995) Protein tyrosine kinase PYK2involved in Ca(2+)-induced regulation of ion channel and MAP kinase func-tions. Nature 376, 737–745.
Dikic I., Tokiwa G., Lev S., Courtneidge S. A., and Schlessinger J. (1996) Arole for PYK2 and Src in linking G-protein-coupled receptors with MAP kinaseactivation. Nature 383, 547–550.
Della Rocca G. J., Maudsley S., Daaka Y., Lefkowitz R. J., and Luttrell L. M. (1999) Pleiotropic coupling of G-protein-coupled receptors to the MAP kinasecascade: Role of focal adhesions and receptor tyrosine kinases. J. Biol. Chem. 274, 13,978–13,984.
Grewal J. S., Luttrell L. M., and Raymond J. R. (2001) G protein-coupled re-ceptorsdesensitize and downregulate EGF receptors in renal mesangial cells. J. Biol. Chem. 276, 27,335–27,344.
Pak Y., Pham N., and Rotin D. (2002) Direct binding of the beta1 adrenergicreceptor to the cyclic AMP-dependent guanine nucleotide exchange factorCNrasGEF leads to Ras activation. Mol. Cell. Biol. 22, 7942–7952.
Karoor V. and Malbon C. C. (1998) G-protein-linked receptors as substrates fortyrosine kinases: cross-talk in signaling. Adv. Pharmacol. 42, 425–428.
Ali M. S., Sayeski P. P., Dirksen L. B., Hayzer D. J., Marrero M. B., and Bernstein K. E. (1997) Dependence on the motif YIPP for the physical associa-tionof Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1receptor. J. Biol. Chem. 272, 23,382–23,388.
Marrero M. B., Venema V. J., Ju H., Eaton D. C., and Venema R. C. (1998) Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles ofSHP-1 and SHP-2. Am. J. Physiol. 275, C1216–C1223.
Hunt R. A., Bhat G. J., and Baker K. M. (1999) Angiotensin II-stimulated in-ductionof sis-inducing factor is mediated by pertussis toxin-insensitive G(q) pro-teinsin cardiac myocytes. Hypertension 34, 603–608.
Cao W., Luttrell L. M., Medvedev A. V., et al. (2000) Direct binding of acti-vatedc-Src to the beta 3-adrenergic receptor is required for MAP kinase activa-tion. J. Biol. Chem. 275, 38,131–38,134.
Miller W. E. and Lefkowitz R. J. (2001) Expanding roles for beta-arrestins asscaffolds and adapters in GPCR signaling and trafficking. Curr. Opin. Cell Biol. 13, 139–145.
Perry S. J. and Lefkowitz R. J. (2002) Arresting developments in heptahelicalreceptor signaling and regulation. Trends Cell Biol. 12, 130–138.
Tohgo A., Pierce K. L., Choy E. W., Lefkowitz R. J., and Luttrell L. M. (2002) Beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activitybut inhibits ERK-mediated transcription following angiotensin AT1a receptorstimulation. J. Biol. Chem. 277, 9429–9436.
Ahn S., Wei H., Garrison T. R., and Lefkowitz R. J. (2004) Reciprocal regu-lationof angiotensin receptor-activated extracellular signal-regulated kinases bybeta-arrestins 1 and 2. J. Biol. Chem. 279, 7807–7811.
Azzi M., Charest P. G., Angers S., et al. (2003) Beta-arrestin-mediated activa-tionof MAPK by inverse agonists reveals distinct active conformations for Gprotein-coupled receptors. Proc. Natl. Acad. Sci. USA 100, 11,406–11,411.
DeFea K. A., Zalevsky J., Thoma M. S., Dery O., Mullins R. D., and Bunnett N. W. (2000) β-Arrestin-dependent endocytosis of proteinase-activated receptor2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148, 1267–1281.
Luttrell L. M., Roudabush F. L., Choy E. W., et al. (2001) Activation and tar-getingof extracellular signal-regulated kinases by β-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98, 2449–2454.
DeFea K. A., Vaughn Z. D., O’Bryan E. M., Nishijima D., Dery O., and Bunnett N. W. (2000) The proliferative and antiapoptotic effects of substance Pare facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. USA 97, 11,086–11,091.
Scott M. G., Le Rouzic E., Perianin A., et al. (2002) Differential nucleocyto-plasmicshuttling of beta-arrestins. Characterization of a leucine-rich nuclear ex-portsequence in beta-arrestin2. J. Biol. Chem. 277, 37,693–37,701.
Lin F-T., Miller W. E., Luttrell L. M., and Lefkowitz R. J. (1999) Feedbackregulation of beta-arrestin1 function by extracellular signal-regulated kinases. J. Biol. Chem. 274, 15,971–15,974.
Pitcher J. A., Tesmer J. J., Freeman J. L., Capel W. D., Stone W. C., and Lefkowitz R. J. (1999) Feedback inhibition of G protein-coupled receptor ki-nase2 (GRK2) activity by extracellular signal-regulated kinases. J. Biol. Chem. 274, 34,531–34,534.
Ogier-Denis E., Pattingre S., El Benna J., and Codogno P. (2000) Erk1/2-de-pendentphosphorylation of Galpha-interacting protein stimulates its GTPase ac-celeratingactivity and autophagy in human colon cancer cells. J. Biol. Chem. 275, 39,090–39,095.
Elorza A., Penela P., Sarnago S., and Mayor F., Jr. (2003) MAPK-dependentdegradation of G protein-coupled receptor kinase 2. J. Biol. Chem. 278, 29,164–29,173.
Ge L., Ly Y., Hollenberg M., and DeFea K. (2003) A beta-arrestin-dependentscaffold is associated with prolonged MAPK activation in pseudopodia duringprotease-activated receptor-2-induced chemotaxis. J. Biol. Chem. 278, 34,418–34,426.
Fong A. M., Premont R. T., Richardson R. M., Yu Y. R., Lefkowitz R. J., and Patel D. D. (2002) Defective lymphocyte chemotaxis in beta-arrestin2-andGRK6-deficient mice. Proc. Natl. Acad. Sci. USA 99, 7478–7483.
McDonald P. H., Chow C-W., Miller W. E., et al. (2000) β-Arrestin 2: a receptor-regulatedMAPK scaffold for the activation of JNK3. Science 290, 1574–1577.
Miller W. E., McDonald P. H., Cai S. F., Field M. F., Davis R. J., and Lefkowitz R. J. (2001) Identification of a motif in the carboxy terminus of β-arrestin2 responsible for activation of JNK3. J. Biol. Chem. 276, 27,770–27,777.
Sun Y., Cheng Z., Ma L., and Pei G. (2002) Beta-arrestin 2 is critically in-volvedin CXCR4-mediated chemotaxis, and this is mediated by its enhancementof p38 MAPK activation. J. Biol. Chem. 277, 49,212–49,219.
Luttrell L. M., Ferguson S. S. G., Daaka Y., et al. (1999) β-Arrestin-dependentformation of β2 adrenergic receptor/Src protein kinase complexes. Science 283, 655–661.
Barlic J., Andrews J. D., Kelvin A. A., et al. (2000) Regulation of tyrosinekinase activation and granule release through β-arrestin by CXCRI. Nat. Immunol. 1, 227–233.
Ghalayini A. J., Desai N., Smith K. R., Holbrook R. M., Elliott M. H., and Kawakatsu H. (2002) Light-dependent association of Src with photoreceptorrod outer segment membrane proteins in vivo. J. Biol. Chem. 277, 1469–1476.
Milano S. K., Pace H. C., Kim Y. M., Brenner C., and Benovic J. L. (2002) Scaffolding functions of arrestin-2 revealed by crystal structure and mutagen-esis. Biochemistry 41, 3321–3328.
Miller W. E., Maudsley S., Ahn S., Kahn K. D., Luttrell L. M., and Lefkowitz R. J. (2000) β-Arrestin1 interacts with the catalytic domain of the tyrosine kinasec-SRC. J. Biol. Chem. 275, 11,312–11,319.
Ahn S., Kim J., Lucaveche C. L., et al. (2002) Src-dependent tyrosine phospho-rylationregulates dynamin self-assembly and ligand-induced endocytosis of theepidermal growth factor receptor. J. Biol. Chem. 277, 26,642–26,651.
Penela P., Elorza A., Sarnage S., and Mayor F., Jr. (2001) Beta-arrestin and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. EMBO J. 20, 5129–5138.
Imamura T., Huang J., Dalle S., et al. (2001) Beta-Arrestin-mediated recruit-mentof the Src family kinase Yes mediates endothelin-1-stimulated glucosetransport. J. Biol. Chem. 276, 43,663–43,667.
Luttrell L. M. (2003) Location, Location, Location. Spatial and temporal regula-tionof MAP kinases by G protein-coupled receptors. J. Mol. Endocrinol. 30, 117–126.
Yang M., Zhang H., Voyno-Yasenetskaya T., and Ye R. D. (2003) Require-mentof G beta-gamma and c-Src in D2 dopamine receptor-mediated nuclearfactor-kappa B activation. Mol. Pharmacol. 64, 447–455.
Chen W., Hu L. A., Semenov M. V., et al. (2001) Beta-Arrestin1 modulateslymphoid enhancer factor transcriptional activity through interaction with phos-phorylateddishevelled proteins. Proc. Natl. Acad. Sci. USA 98, 14,889–14,894.
Chen W., ten Berge D., Brown J., et al. (2003) Dishevelled 2 recruits beta-arrestin2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301, 1391–1394.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Luttrell, L.M. (2006). Transmembrane Signaling by G Protein-Coupled Receptors. In: Ali, H., Haribabu, B. (eds) Transmembrane Signaling Protocols. Methods in Molecular Biology™, vol 332. Humana Press. https://doi.org/10.1385/1-59745-048-0:1
Download citation
DOI: https://doi.org/10.1385/1-59745-048-0:1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-546-0
Online ISBN: 978-1-59745-048-5
eBook Packages: Springer Protocols